Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t (8; 21) acute myeloid leukemia: A prospective, randomized study
Author:
Affiliation:
1. Department of Hematology; Institute of Hematology, Changhai Hospital, Shanghai; China
2. Department of Hematology; Shanghai Jiao Tong University Affiliated First People's Hospital; Shanghai China
Funder
National Natural Science Foundation of China
Shanghai Health Bureau
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24569/fullpdf
Reference23 articles.
1. Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom medical research council trials;Grimwade;Blood,2010
2. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: A survey of the German acute myeloid leukemia intergroup;Schlenk;J Clin Oncol,2004
3. Incidence and prognostic impact of c-kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML);Boissel;Leukemia,2006
4. Prognostic impact of c-kit mutations in core binding factor leukemias: An Italian retrospective study;Cairoli;Blood,2006
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different‐from‐normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation;International Journal of Laboratory Hematology;2019-06-04
2. Polyphyllin I Inhibits Proliferation and Induces Apoptosis by Downregulating AML1-ETO and Suppressing C-KIT/Akt Signaling in t(8;21) Acute Myeloid Leukemia;Chemistry & Biodiversity;2018-10-26
3. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation;Terapevticheskii arkhiv;2018-07-15
4. Angiomodulators in cancer therapy: New perspectives;Biomedicine & Pharmacotherapy;2017-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3